Cardiac mechanotransduction: from sensing to disease and treatment (Q34243174)

31 July 2017

1 reference

title

Cardiac mechanotransduction: from sensing to disease and treatment (English)

1 reference

31 July 2017

1 reference

Tavi P

1

1 reference

31 July 2017

Laine M

series ordinal

2

1 reference

31 July 2017

Weckström M

series ordinal

3

1 reference

31 July 2017

Ruskoaho H

series ordinal

4

1 reference

31 July 2017

language of work or name

1 reference

1 May 2001

1 reference

Trends in Pharmacological Sciences

31 July 2017

published in

1 reference

31 July 2017

volume

22

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

254-260

1 reference

Mechanisms of stretch-induced changes in [Ca2+]i in rat atrial myocytes: role of increased troponin C affinity and stretch-activated ion channels.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Stretch-activated and background non-selective cation channels in rat atrial myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Changes in force and cytosolic Ca2+ concentration after length changes in isolated rat ventricular trabeculae

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Regulation of Stretch-Activated Intracellular Calcium Transients by Actin Filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

The human heart endothelin system: ET-1 synthesis, storage, release and effect

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Mechanisms underlying the increase in force and Ca(2+) transient that follow stretch of cardiac muscle: a possible explanation of the Anrep effect

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Intracellular acidosis modulates the stretch-induced changes in E-C coupling of the rat atrium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

The effect of Ca(2+)-calmodulin-dependent protein kinase II on cardiac excitation-contraction coupling in ferret ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Pressure Overload Induces Severe Hypertrophy in Mice Treated With Cyclosporine, an Inhibitor of Calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Calcineurin inhibitors and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Signal transduction in atria and ventricles of mice with transient cardiac expression of activated G protein alpha(q)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Signaling in myocardial hypertrophy: life after calcineurin?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

1 reference

7 January 2021

Functional consequences of altering myocardial adrenergic receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Intracellular signalling through protein kinases in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Endothelial cell storage and release of endothelin as a cardioregulatory mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

The cellular and molecular response of cardiac myocytes to mechanical stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

GATA transcription factors and cardiac development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Transcription factors of the NFAT family: regulation and function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

GATA-dependent recruitment of MEF2 proteins to target promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Combinatorial interactions regulating cardiac transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Transcriptional regulation during cardiac growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Molecular mechanisms of myocardial remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Abnormalities of calcium cycling in the hypertrophied and failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Length dependence of calcium- and force-transients in normal and failing human myocardium.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Signaling pathways for cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Normalization of diastolic dysfunction in aortic stenosis late after valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

A Drosophila mechanosensory transduction channel

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Cloning and expression of human TRAAK, a polyunsaturated fatty acids-activated and mechano-sensitive K(+) channel

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901679-5

7 January 2021

10.1016/S0165-6147(00)01679-5

Identifiers

DOI

1 reference

31 July 2017

1 reference